NEW DELHI--August 27, 2024--Researched by Industrial Info Resources (Sugar Land, Texas)--The market for radioactive diagnostic substances is witnessing significant expansion in Europe owing to advancements in nuclear medicine, growing incidences of chronic illnesses and rising demand for high-accuracy diagnostic tools. As the healthcare industry continues to evolve, radioactive diagnostic substances are being increasingly used as a vital medical tool in early detection and effective treatment of the diseases.